Innovation Quarter News

From Bench to the Clinic: View the Presentation on Regulatory and Clinical Drug Development Strategies

On May 14, 2013, Margaretha Oortgiesen, PhD, VP of Drug Development and Managing Director, CATO Research, presented at Wake Forest Innovation Quarter on aspects for consideration when taking a medicinal product (drug, biologic, or drug/device combination product) from the discovery phase into the first exposure in the clinic. View the PowerPoint deck from Dr. Oortgiesen’s presentation.